𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma

✍ Scribed by P. H. M. De Mulder, P. Cappelaere, F. Cognetti…

Book ID
120777411
Publisher
Springer
Year
1994
Tongue
English
Weight
296 KB
Volume
33
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of mitoxantrone in advanc
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck
✍ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap

A phase II study of piritrexim in patien
A phase II study of piritrexim in patients with advanced squamous head and neck cancer
✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the